6 completed, 1 terminated, 1 unknown. 8 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 6, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Hemangiopericytoma, Malignant: new trials by email Literature Review of Hemangiopericytoma, Malignant trials Research Report on Hemangiopericytoma, Malignant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma doxorubicin hydrochloride, trabectedin, laboratory biomarker analysis - Sarcoma | Phase 2 / Phase 3 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 133 | 2011-05-01 | 2014-08-08 |
| Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma doxorubicin hydrochloride, clinical observation, therapeutic conventional surgery - Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma | Phase 3 | Completed | Children's Oncology Group | 588 | 2007-02-05 | 2022-04-28 |
| Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma radiotherapy - Sarcoma | Phase 3 | Completed | Sheffield Teaching Hospitals NHS Foundation Trust | 216 | 2006-03-01 | 2021-03-18 |
| Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma doxorubicin hydrochloride, ifosfamide, adjuvant therapy - Childhood Malignant Fibrous Histiocytoma of Bone, Sarcoma | Phase 3 | Unknown | European Paediatric Soft Tissue Sarcoma Study Group | 250 | 2006-03-01 | 2013-08-12 |
| Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma doxorubicin hydrochloride, ifosfamide - Sarcoma | Phase 3 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 780 | 1998-01-01 | 2012-01-20 |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma filgrastim, doxorubicin hydrochloride, ifosfamide - Endometrial Cancer, Kidney Cancer | Phase 3 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 340 | 1996-04-01 | 2012-07-11 |
| Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma filgrastim, doxorubicin hydrochloride, ifosfamide - Endometrial Cancer, Kidney Cancer | Phase 3 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 350 | 1995-02-01 | 2014-08-08 |
| Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma dactinomycin, carboplatin, cyclophosphamide - Childhood Malignant Fibrous Histiocytoma of Bone, Sarcoma | Phase 3 | Completed | Societe Internationale d'Oncologie Pediatrique | 400 | 1995-01-01 | 2013-12-04 |
Fibrosarcoma (8) · Hemangiosarcoma (8) · Sarcoma (8) · Liposarcoma (7) · Histiocytoma, Malignant Fibrous (6) · Leiomyosarcoma (6) · Malignant mesenchymal tumor (6) · Neurofibrosarcoma (6) · Sarcoma, Synovial (6) · Sarcoma, Alveolar Soft Part (4) · Chondrosarcoma, Extraskeletal Myxoid (3) · Dermatofibrosarcoma (2) · Desmoplastic Small Round Cell Tumor (2) · Endometrial Neoplasms (2)
Neoplasms (8) · Neoplasms by Histologic Type (8) · Neoplasms, Connective Tissue (8) · Neoplasms, Connective and Soft Tissue (8) · Neoplasms, Fibrous Tissue (8) · Neoplasms, Vascular Tissue (8) · Neoplasms, Adipose Tissue (7) · Neoplasms, Nerve Tissue (7) · Histiocytoma (6) · Neoplasms, Muscle Tissue (6) · Nerve Sheath Neoplasms (6) · Nervous System Diseases (6) · Nervous System Neoplasms (6) · Neurofibroma (6) · Neuromuscular Diseases (6)
Doxorubicin (6) · Ifosfamide (6) · Radiotherapy (4) · Chemotherapy, Adjuvant (3) · Filgrastim (2) · Neoadjuvant Therapy (2) · Brachytherapy (1) · Carboplatin (1) · Cyclophosphamide (1) · Dactinomycin (1) · Epirubicin (1) · Etoposide (1) · Observation (1) · Radiotherapy, Conformal (1) · Trabectedin (1)
European Organisation for Research and Treatment of Cancer - EORTC (4) · Children's Oncology Group (1) · European Paediatric Soft Tissue Sarcoma Study Group (1) · Sheffield Teaching Hospitals NHS Foundation Trust (1) · Societe Internationale d'Oncologie Pediatrique (1)
United Kingdom (6) · Belgium (4) · Denmark (4) · France (4) · Spain (4) · Austria (3) · Germany (3) · Netherlands (3) · Slovakia (3) · Switzerland (3) · Canada (2) · Hungary (2) · Poland (2) · Sweden (2) · United States (2)
A.N. Van Geel, MD (1) · Andrea Ferrari, MD (1) · Bernadette Brennan, MD (1) · James E. Butrynski, MD (1) · Joern Treuner, MD (1) · Laurence H. Baker, DO, FACOI (1) · M. C. G. Stevens, MD (1) · Martin Robinson, MD (1) · Max Van Noesel, MD, PhD (1) · Modesto Carli, MD (1) · Nguyen Binh Bui, MD (1) · Paul C. Lorigan, MD (1) · Penella J. Woll, MD, PhD (1) · Ronald H. Blum, MD (1) · Sheri Spunt, MD (1)
PMID 17634494, PMID 22665534, PMID 22954508, PMID 28391003, PMID 30954717, PMID 31786124, PMID 33548339, PMID 34623899, PMID 36566574, PMID 38757485, PMID 39122389, PMID 41386267
2009 (1), U10CA098543 (1)